Scheme 2. Conditions: (a) N,N-di-t-butylformamide dimethyl acetal, DMF, room temperature, 3 h; (b) diphenylcarbamoyl chloride, i-Pr2NEt, room temperature, 2 h, 97% (two steps); (c) TBAF, THF, 0°C–room temperature, 1 h, 87%; (d) DMTrCl, pyridine, room temperature, 1 h, 82%; (e) 2-cyanoethyl N,N-diisopropylchlorophosphoramidite, i-Pr2NEt, CH2Cl2, room temperature, 20 min, 90%.